google-site-verification: googlec7193c3de77668c9.html
Tuesday , September 22 2026

FDA approves first stem cell therapy for severe aplastic anemia

[
The U.S. Food and Drug Administration has approved Omisirge (omidubicel-onlv) as the first hematopoietic stem cell transplant therapy to treat patients with severe aplastic anemia (SAA).


Source link

Advertisements

See also  Freestanding birth centers are closing as maternity care gaps grow

Check Also

Base editing corrects mutation and slows motor neuron disease in mouse model

[ Graphical abstract. Credit: Molecular Therapy Advances (2026). DOI: 10.1016/j.omta.2026.201835 In a study published in …

Invitation for men to ‘experience hot flushes’ at Hull event

Partners of women going through the menopause are being invited to experience one of the …

Smelling freshly brewed coffee briefly improves mood, small study suggests

[ Just exposure to coffee aroma led to lower overall mood disturbance in university students. …

Leave a Reply

Available for Amazon Prime